Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting

Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis

(2020) Siok Shen Ng et al.   Scientific Reports

Optimising clinical effectiveness and quality along the atrial fibrillation anticoagulation pathway: an economic analysis

(2019) Eoin Moloney et al.   BMC HEALTH SERVICES RESEARCH

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation

(2018) Erik Lerkevang Grove et al.   Scientific Reports

Societal Costs of First-Incident Ischemic Stroke in Patients with Atrial Fibrillation—A Danish Nationwide Registry Study

(2016) Marie Jakobsen et al.   VALUE IN HEALTH

Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses

(2016) Xue Li et al.   PLoS One

Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist

(2015) Misericòrdia Carles et al.   BMC HEALTH SERVICES RESEARCH

Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation

(2015) Peter Brønnum Nielsen et al.   CHEST

Association Between Atrial Fibrillation and Costs After Myocardial Infarction: A Community Study

(2015) Bijan J. Borah et al.   CLINICAL CARDIOLOGY

A Health Economic Evaluation of Stroke Prevention in Atrial Fibrillation: Guideline Adherence Versus the Observed Treatment Strategy Prior to 2012 in Denmark

(2015) Anne Sig Vestergaard et al.   PHARMACOECONOMICS

Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium

(2014) Thitima Kongnakorn et al.   CLINICAL DRUG INVESTIGATION

Patient Self-Management of Oral Anticoagulation with Vitamin K Antagonists in Everyday Practice: Efficacy and Safety in a Nationwide Long-Term Prospective Cohort Study

(2014) Michael Nagler et al.   PLoS One

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

(2013) Don Husereau et al.   VALUE IN HEALTH

Home-monitoring of oral anticoagulation vs. dabigatran

(2012) Qi Zhou et al.   THROMBOSIS AND HAEMOSTASIS

Catalogue of EQ-5D Scores for the United Kingdom

(2011) Patrick W. Sullivan et al.   MEDICAL DECISION MAKING

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of Early and Late Case-Fatality in a Nationwide Danish Study of 26 818 Patients With First-Ever Ischemic Stroke

(2011) Klaus Kaae Andersen et al.   STROKE

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective

(2011) Anuraag Kansal et al.   THROMBOSIS AND HAEMOSTASIS

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Effect of Home Testing of International Normalized Ratio on Clinical Events

(2010) David B. Matchar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE